pyridoxal has been researched along with Cholestasis, Intrahepatic in 1 studies
Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, DN | 1 |
| Sharp, PF | 1 |
| Brunt, PW | 1 |
| Mowat, NA | 1 |
| Dascombe, G | 1 |
| Smith, FW | 1 |
1 trial available for pyridoxal and Cholestasis, Intrahepatic
| Article | Year |
|---|---|
Hepatobiliary imaging using Tc-pyridoxylideneglutamate in the diagnosis of obstructive jaundice.
Topics: Cholestasis; Cholestasis, Extrahepatic; Cholestasis, Intrahepatic; Glutamates; Humans; Organotechnet | 1982 |